| Literature DB >> 12926179 |
Abstract
Although SSRIs are widely used and generally considered safe, an abrupt cessation of SSRI use may result in a discontinuation syndrome that can mimic serious illness and can be distressing and uncomfortable. Several pharmacokinetic and pharmacodynamic factors influence the frequency and onset of these symptoms. Rapid identification of SSRI discontinuation syndrome and reinstitution of the medication can provide rapid symptom relief. Ongoing education and discussion about the illness and its treatment can promote medication compliance and thus minimize the potential for sudden cessation of the SSRI, the uncomfortable experience of discontinuation symptoms, and unnecessary medical expenditures.Entities:
Mesh:
Substances:
Year: 2003 PMID: 12926179 DOI: 10.3810/pgm.2003.08.1474
Source DB: PubMed Journal: Postgrad Med ISSN: 0032-5481 Impact factor: 3.840